Search - tctmd.com

Displaying 61 - 80 of 103

Sort: Relevancy | Date

News Daily News

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

October 01, 2015

News Daily News

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

October 01, 2015

News Daily News

El Mejor Grado de Sobredimensionamiento Varía en función del Dispositivo TAVR

Caitlin E. Cox

April 17, 2015

News Daily News

Best Degree of Oversizing Varies by TAVR Device

Caitlin E. Cox

April 17, 2015

News Daily News

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Todd Neale

April 10, 2015

News Conference News ACC 2015

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Todd Neale

March 15, 2015

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

Lively Debate on Use of TAVR for Lower-Risk Patients

September 14, 2014

Presentation TCT 2014

Updates from SURTAVI in Intermediate-Risk Patients

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Patrick W. Serruys

September 13, 2014

Presentation TCT 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presenter: Jodi Akin

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

Presentation TCT 2013

Status Update on the Randomized Moderate Risk AS Trials: SURTAVI

Presenter: Patrick Serruys

October 27, 2013

Presentation TVT 2013

Updates from SURTAVI

Presenter: Nicolas van Mieghem

June 13, 2013

News Daily News

Meta-análisis: Aumenta la prevalencia de la enfermedad y el número de candidatos a TAVR

Yael L. Maxwell

May 31, 2013

Advertisement

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

El Mejor Grado de Sobredimensionamiento Varía en función del Dispositivo TAVR

Best Degree of Oversizing Varies by TAVR Device

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

TCT Course Director Outlines Current TAVR Controversies

Lively Debate on Use of TAVR for Lower-Risk Patients

Updates from SURTAVI in Intermediate-Risk Patients

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Two Trials to Assess TAVR in Moderate-Risk Patients

Status Update on the Randomized Moderate Risk AS Trials: SURTAVI

Updates from SURTAVI

Meta-análisis: Aumenta la prevalencia de la enfermedad y el número de candidatos a TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content